Literature DB >> 9715268

p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells.

Z E Winters1, W M Ongkeko, A L Harris, C J Norbury.   

Abstract

We have investigated the influence of p53 on radiation-induced G2 cell cycle arrest using human H1299 cells expressing temperature-sensitive p53. Gamma-irradiated cells lacking p53 arrested transiently in G2 with Cdc2 extensively phosphorylated at the inhibitory sites Thr14 and Tyr15, and with both Cdc2 and cyclin B1 restricted to the cytoplasm. Activation of p53 by temperature shift resulted in a more protracted G2 arrest that could not be overridden by checkpoint-abrogating drugs. Surprisingly, this enhancement of G2 arrest was associated with a marked lack of inhibitory phosphorylation of Cdc2 and with the nuclear localization of both Cdc2 and cyclin B1. While transient expression of an A14F15 mutant form of Cdc2 that is not subject to inhibitory phosphorylation induced mitotic catastrophe in cells lacking p53, the p53-expressing cells were relatively refractory to this effect. Enforced expression of p21WAF1/CJP1 was sufficient to confer nuclear localization on Cdc2 in the p53 null cells, though immunodepletion experiments demonstrated that only a small proportion of Cdc2 was stably associated with p21WAF1/CJP1 in the p53-expressing cells. We conclude that a p53-dependent pathway can operate after exposure of human cells to ionising radiation to promote G2 arrest accompanied by nuclear translocation rather than inhibitory phosphorylation of Cdc2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715268     DOI: 10.1038/sj.onc.1201991

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells.

Authors:  C Badie; J E Itzhaki; M J Sullivan; A J Carpenter; A C Porter
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.

Authors:  P M Flatt; L J Tang; C D Scatena; S T Szak; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Cell growth inhibition, G2M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803.

Authors:  Xia Liu; Jingze Wang; Bo Sun; Yajing Zhang; Jin Zhu; Changling Li
Journal:  Invest New Drugs       Date:  2007-07-10       Impact factor: 3.850

Review 5.  Senescence from G2 arrest, revisited.

Authors:  Véronique Gire; Vjekoslav Dulic
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage.

Authors:  D R Duckett; S M Bronstein; Y Taya; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  Mechanisms of G2 arrest in response to overexpression of p53.

Authors:  W R Taylor; S E DePrimo; A Agarwal; M L Agarwal; A H Schönthal; K S Katula; G R Stark
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

Review 8.  The enigmatic effects of caffeine in cell cycle and cancer.

Authors:  Ann M Bode; Zigang Dong
Journal:  Cancer Lett       Date:  2006-05-18       Impact factor: 8.679

9.  Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts.

Authors:  Fabienne Baus; Véronique Gire; Daniel Fisher; Jacques Piette; Vjekoslav Dulić
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

10.  p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress.

Authors:  Fabienne Baus Charrier-Savournin; Marie-Thérèse Château; Véronique Gire; John Sedivy; Jacques Piette; Vjekoslav Dulic
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.